Notice: Trying to get property 'slug' of non-object in /home/sgumdev/public_html/wp-content/themes/sgum_2016/single.php on line 44

written by reader Venture Technology

By pswms, November 16, 2017

they want $5000 + a year to subscribe…
Beginning Dec. 31st, one little-known company could receive worldwide approval for a new medical treatment that will successfully treat 50% of patients with the worst disease faced by U.S. seniors and retirees.
The stock could soar 200% once approval comes through. Three times your money… on a single investment right now.
We’re sharing the full details in Venture Technology

I searched it at stockgumshoe and could not find a reference…. confident of their product, I believe, they have offered two years free access for the purchase of one year subscription…

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.



This site uses Akismet to reduce spam. Learn how your comment data is processed.

Inline Feedbacks
View all comments
5 years ago

Wow, $5,000 is one of the highest subscriptions around…. and they’re only offering one suggestion to start…. which they say “could” be approved.

I’m so glad I found Stock Gumshoe, Travis and the Thinkolator and the Gummies who think these things through just to help the community.

Maybe we should /could figure out what the disease is, now that the high blood pressure guidelines are lower than they were last week. The mystery stock “could … treat 50% of patients with the worst disease faced by U.S. seniors and retirees”.

Add a Topic
Add a Topic
Add a Topic
👍 195
5 years ago

Is Ventyre Technology a typo for Venture Technology?

👍 3
5 years ago

$VRAY (full position)
I’m guessing Varian or ViewRay. More investigation will make this one obvious…
I’m went ViewRay but admit my diligence was (somewhat) quick.

👍 157

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

More Info